 |
Management Team
John Corcoran
CEO
John E. Corcoran is the CEO and Managing Partner Trinity Pharma Solutions and
Trinity Partners, LLC. He has over 15 years consulting experience in
pharmaceuticals and biotechnology with particular interests in
commercialization strategy and data management. John attended Harvard College
where he received an A.B. degree magna cum laude. He also holds graduate
degrees from Northeastern University and the John F. Kennedy School of
Government at Harvard. John is a co-founder and member of the board of
directors of Soteira, Inc., a Natick, Massachusetts-based medical device
company that is pioneering new approaches to spinal surgery based on stent
technology.
Zackary King
Director of Technology
Zackary King has over 13 years experience managing high-tech companies and projects in Europe and the United States.
As director of technology at Trinity Pharma
Solutions, he is responsible for leading, designing, and growing the company's
technology practice and product suite. He is also involved as a principal engineer and technology
adviser, participating in business development and corporate strategic initiatives.
With a depth of knowledge in systems design, database
architecture, and emerging technologies, Zackary has spent much of his career
providing state-of-the-art solutions for clients such as
Gillette and Johnson & Johnson as well as a number of start-ups.
Prior to Trinity Zackary held a senior position with ZEFER - an Internet consulting and services
firm that closed $160M in funding with clients that included Morgan Stanley, Citigroup, Citizens Bank, Siemens, Lucent and a
range of new venture companies.
Zackary is focused on leading Trinity's vision to provide industry leading platforms for
biotech and pharmaceutical data management and visualization. Zackary holds a BS in Computer Science from
Bentley.
Glenn Wong
Director of Operations
As director of business operations and analytics, Glenn Wong is responsible for
ongoing client service, business development, and staff development. With his
team of business analysts and an in-depth knowledge of syndicated
pharmaceutical data, Glenn helps clients manage over $2 billion of sales data
annually and provides analytic support for their commercial sales operations.
Prior to joining Trinity in 2003, Glenn was a consultant with McKinsey &
Company, working with senior executives and board members of major corporations
to address top-level strategic and operational challenges. Glenn holds a Ph.D.
in Experimental Physics from Harvard University and a B.S. (Honors) in Physics
from Stanford University.
|
|
